NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDAlemtuzumab Lemtrada® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDDimethyl fumarate 120mg & 240mg Tecfidera®
(Capsules) 		Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04
REDPeginterferon beta-1a Plegridy®
(Pre-filled pen) 		Malignant disease and immunosuppression, Interferon Alfa, 08.02.04
Amber SPISTizanidine 2mg and 4mg tablets  Musculoskeletal and joint diseases, Skeletal muscle relaxants, 10.02.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Alemtuzumab Alemtuzumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Cladribine Cladribine Immune System, Antineoplastic Drugs, Antimetabolites
Immune System Disorders And Transplantation, Multiple Sclerosis
Dimethyl  Dimethyl Fumarate Immune System, Immunosuppressants, Immunomodulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
Diroximel  Diroximel Fumarate Immune System, Immunosuppressants, Immunomodulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
FampridineFampridine Immune System, Cholinergic Receptor Stimulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
Fingolimod  Fingolimod Immune System, Immunosuppressants, Immunomodulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
Glatiramer  Glatiramer Acetate Immune System, Immunostimulants, Immunostimulants, Other
Immune System Disorders And Transplantation, Multiple Sclerosis
Interferon  Interferon Beta Immune System, Immunostimulants, Interferons
Immune System Disorders And Transplantation, Multiple Sclerosis
Natalizumab Natalizumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Ocrelizumab Ocrelizumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Ofatumumab Ofatumumab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Ozanimod  Ozanimod Immune System, Immunosuppressants, Immunomodulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
Peginterferon  Peginterferon Beta-1A Immune System, Immunostimulants, Interferons
Immune System Disorders And Transplantation, Multiple Sclerosis
Ponesimod Ponesimod Immune System, Immunosuppressants, Immunomodulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
Siponimod  Siponimod Immune System, Immunosuppressants, Immunomodulating Drugs
Immune System Disorders And Transplantation, Multiple Sclerosis
Teriflunomide Teriflunomide Immune System, Immunosuppressants, Pyrimidine Synthesis Inhibitors
Immune System Disorders And Transplantation, Multiple Sclerosis
Ublituximab Ublituximab Immune System, Immunosuppressants, Monoclonal Antibodies
Immune System Disorders And Transplantation, Multiple Sclerosis
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE NG220 Multiple sclerosis in adults: management
NICE TA 1126: Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy
NICE TA 616 Cladribine for treating relapsing–remitting multiple sclerosis
NICE TA 624 Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis
NICE TA 656 Siponimod for treating secondary progressive multiple sclerosis
NICE TA 767 Ponesimod for treating relapsing–remitting multiple sclerosis
NICE TA1025: Ublituximab for treating relapsing multiple sclerosis
NICE TA1053: Cladribine for treating active relapsing forms of multiple sclerosis
NICE TA127: Multiple sclerosis - natalizumab
NICE TA254: Fingolimod for highly active relapsing remitting multiple sclerosis
NICE TA312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis
NICE TA312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis
NICE TA320: Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis
NICE TA441: Daclizumab for treating relapsing–remitting multiple sclerosis
NICE TA527: Beta interferons and glatiramer acetate for treating multiple sclerosis
NICE TA533: Ocrelizumab for treating relapsing–remitting multiple sclerosis
NICE TA585 Ocrelizumab for treating primary progressive multiple sclerosis
NICE TA699: Ofatumumab for treating relapsing multiple sclerosis
NICE TA794 Diroximel fumarate for treating relapsing–remitting multiple sclerosis
SCG: Alemtuzumab for treating relapsing-remitting multiple sclerosis